LRRC59 Antikörper
-
- Target Alle LRRC59 Antikörper anzeigen
- LRRC59 (Leucine Rich Repeat Containing 59 (LRRC59))
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser LRRC59 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (IF), Immunocytochemistry (ICC)
- Kreuzreaktivität
- Human, Maus
- Aufreinigung
- Purified by antigen-affinity chromatography.
- Güteklasse
- KO Validated
- Immunogen
- Recombinant protein encompassing a sequence within the center region of human LRRC59. The exact sequence is proprietary.
- Isotyp
- IgG
- Top Product
- Discover our top product LRRC59 Primärantikörper
-
anti-Leucine Rich Repeat Containing 59 (LRRC59) (AA 1-244) antibody
LRRC59 Reaktivität: Human WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Leucine Rich Repeat Containing 59 (LRRC59) (Middle Region) antibodyLRRC59 Reaktivität: Human, Maus, Ratte, Hund, Kaninchen, Rind (Kuh), Meerschweinchen, Schwein, Pferd WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Leucine Rich Repeat Containing 59 (LRRC59) (N-Term) antibodyLRRC59 Reaktivität: Human, Maus, Ratte, Hund, Rind (Kuh), Meerschweinchen, Schwein, Affe, Fledermaus WB, IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Leucine Rich Repeat Containing 59 (LRRC59) (N-Term) antibodyLRRC59 Reaktivität: Human, Maus, Ratte, Hund, Kaninchen, Rind (Kuh), Meerschweinchen WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Leucine Rich Repeat Containing 59 (LRRC59) (AA 201-250) antibodyLRRC59 Reaktivität: Human, Maus, Ratte, Hund, Kaninchen, Schwein, Affe WB, IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Leucine Rich Repeat Containing 59 (LRRC59) (AA 1-244) antibodyKO Validated LRRC59 Reaktivität: Human WB, IHC, IP Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- WB: 1:500-1:3000. ICC/IF: 1:100-1:1000. IHC-P: 1:100-1:1000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
- Kommentare
-
Positive Control: A431 , HeLa , HepG2 , 293T
Validation: KO/KD
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- 1XPBS ( pH 7), 1 % BSA, 20 % Glycerol, 0.01 % Thimerosal
- Konservierungsmittel
- Thimerosal (Merthiolate)
- Vorsichtsmaßnahmen
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
- Target
- LRRC59 (Leucine Rich Repeat Containing 59 (LRRC59))
- Andere Bezeichnung
- leucine rich repeat containing 59 (LRRC59 Produkte)
- Synonyme
- p34 antikoerper, PRO1855 antikoerper, AA959742 antikoerper, C78668 antikoerper, leucine rich repeat containing 59 antikoerper, leucine rich repeat containing 59 S homeolog antikoerper, LRRC59 antikoerper, Lrrc59 antikoerper, lrrc59.S antikoerper
- Hintergrund
- Leucine rich repeat containing 59 , PRO1855 , p34
- Molekulargewicht
- 35 kDa
- Gen-ID
- 55379
- UniProt
- Q96AG4
-
